N163-166 (MOD6)
Shop N163-166 (MOD6) on KimeraChems · code GUIDE (10% off)Definition
N163-166 (MOD6) is a short peptide sequence researched for its potential to influence cellular signaling pathways involved in tissue stress responses and repair dynamics. In research contexts, it is primarily explored as a tool compound for studying localized inflammation signaling, barrier integrity, and downstream remodeling processes in models where healing quality and fibrosis signaling are key variables. Because N163-166 (MOD6) is discussed in niche research settings, outcomes are highly dependent on model selection, route of exposure, tissue target, and study duration.
Available Formats
- Dry fill enteric capsules (commonly 250 mcg, 60 count, 15 mg total)
Mechanism of Action
Research discussion suggests N163-166 (MOD6) may: Because it is not a primary hormone axis compound, results are often evaluated through local markers (inflammation, remodeling, barrier integrity) rather than classic endocrine endpoints.
- Influence pro inflammatory signaling cascades involved in tissue irritation and recovery
- Support more favorable remodeling dynamics by shifting local signaling away from excessive inflammatory persistence
- Affect pathways tied to barrier function and tissue integrity depending on the model
- Act as a research tool for studying inflammation resolution versus chronic signaling states
Areas of Investigation
N163-166 (MOD6) is commonly studied in
- Tissue repair and remodeling research designs
- Fibrosis signaling models where collagen turnover and scarring quality are variables
- Barrier integrity and inflammation resolution paradigms
- Recovery focused models where irritation and inflammation persistence limit performance outcomes
- Comparative studies alongside other repair signaling compounds in controlled settings
Safety Profile
Reported observations include: As with many niche signaling peptides, conservative study design and gradual titration are commonly emphasized in research discussions.
- GI discomfort or sensitivity signals in orally exposed models depending on capsule fill and excipients
- Headache or fatigue like signals in inflammation sensitive research subjects
- Variable appetite or sleep disruption signals in some contexts where inflammatory signaling shifts rapidly
- Unpredictable outcomes when stacked with multiple immune active compounds without clear endpoints
Interaction Notes
N163-166 (MOD6) is often explored alongside compounds that support recovery and inflammation resolution focused research endpoints: Recovery and tissue support models: Caution combinations
- Collagen support substrates and connective tissue focused tools depending on study aim
- Anti inflammatory nutrition variables (omega 3 intake, protein adequacy) when controlling confounders
- Stacking multiple immune active compounds can make signal attribution difficult
- Adding aggressive anti inflammatory agents may blunt the ability to interpret whether N163-166 (MOD6) is driving observed changes
For educational purposes only. Not for human consumption.